Nizal S. Chandrakumar

Array ( [id] => 4681908 [patent_doc_number] => 20080248134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof' [patent_app_type] => utility [patent_app_number] => 12/062732 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10192 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248134.pdf [firstpage_image] =>[orig_patent_app_number] => 12062732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4561692 [patent_doc_number] => 07838691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Palmerolides: methods of preparation and derivatives thereof' [patent_app_type] => utility [patent_app_number] => 12/098001 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 24206 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838691.pdf [firstpage_image] =>[orig_patent_app_number] => 12098001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169089 [patent_doc_number] => 07667040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Azacyclic ethynyl derivatives' [patent_app_type] => utility [patent_app_number] => 12/076929 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9937 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667040.pdf [firstpage_image] =>[orig_patent_app_number] => 12076929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8165191 [patent_doc_number] => 08173813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity' [patent_app_type] => utility [patent_app_number] => 12/054083 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 90701 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173813.pdf [firstpage_image] =>[orig_patent_app_number] => 12054083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618960 [patent_doc_number] => 20100099874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'TRANSANNULAR REARRANGEMENT OF ACTIVATED LACTAMS' [patent_app_type] => utility [patent_app_number] => 12/532067 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6973 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099874.pdf [firstpage_image] =>[orig_patent_app_number] => 12532067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144746 [patent_doc_number] => 20110130403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PYRAZOLO [3, 4-B] PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/531045 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26950 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130403.pdf [firstpage_image] =>[orig_patent_app_number] => 12531045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927932 [patent_doc_number] => 20080167295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Quinolinone-carboxamide compounds' [patent_app_type] => utility [patent_app_number] => 12/075740 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30339 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167295.pdf [firstpage_image] =>[orig_patent_app_number] => 12075740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103267 [patent_doc_number] => 07723533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base' [patent_app_type] => utility [patent_app_number] => 12/046999 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10180 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723533.pdf [firstpage_image] =>[orig_patent_app_number] => 12046999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823444 [patent_doc_number] => 20080227851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'LAULIMALIDE AND LAULIMALIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/046632 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41113 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227851.pdf [firstpage_image] =>[orig_patent_app_number] => 12046632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274410 [patent_doc_number] => 07560576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base' [patent_app_type] => utility [patent_app_number] => 12/046984 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10150 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560576.pdf [firstpage_image] =>[orig_patent_app_number] => 12046984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217296 [patent_doc_number] => 07612206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors' [patent_app_type] => utility [patent_app_number] => 12/044952 [patent_app_country] => US [patent_app_date] => 2008-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16617 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612206.pdf [firstpage_image] =>[orig_patent_app_number] => 12044952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515577 [patent_doc_number] => 08039649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Method of retaining the quality of 2-methyl-3-(3,4-methylenedioxyphenyl)propanal and process for producing the same' [patent_app_type] => utility [patent_app_number] => 12/529719 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10708 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039649.pdf [firstpage_image] =>[orig_patent_app_number] => 12529719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9350475 [patent_doc_number] => 08669366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Process for the preparation of quaternary N-alkyl morphinan alkaloid salts' [patent_app_type] => utility [patent_app_number] => 12/529723 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21565 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12529723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223370 [patent_doc_number] => 20100056616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'IEJIMALID ANALOGA AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/532524 [patent_app_country] => US [patent_app_date] => 2008-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14261 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056616.pdf [firstpage_image] =>[orig_patent_app_number] => 12532524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644861 [patent_doc_number] => 20100227878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'NOSCAPINE ANALOGS AND THEIR USE IN TREATING CANCERS, INCLUDING DRUG-RESISTANT CANCERS' [patent_app_type] => utility [patent_app_number] => 12/530158 [patent_app_country] => US [patent_app_date] => 2008-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20772 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227878.pdf [firstpage_image] =>[orig_patent_app_number] => 12530158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 229026 [patent_doc_number] => 07601839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Pyrrolo-pyridine kinase modulators' [patent_app_type] => utility [patent_app_number] => 12/040536 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 67384 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601839.pdf [firstpage_image] =>[orig_patent_app_number] => 12040536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250881 [patent_doc_number] => 07582637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Pyrrolo-pyridine kinase modulators' [patent_app_type] => utility [patent_app_number] => 12/040527 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 60341 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582637.pdf [firstpage_image] =>[orig_patent_app_number] => 12040527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258587 [patent_doc_number] => 20100029956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'METHOD FOR PRODUCING ESTER OR LACTONE' [patent_app_type] => utility [patent_app_number] => 12/530136 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16816 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029956.pdf [firstpage_image] =>[orig_patent_app_number] => 12530136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4471327 [patent_doc_number] => 07943772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Crystalline forms of an 8-azabicyclo(3.2.1)octane compound' [patent_app_type] => utility [patent_app_number] => 12/072534 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 16829 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943772.pdf [firstpage_image] =>[orig_patent_app_number] => 12072534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159768 [patent_doc_number] => 07674921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Internal 1,15-lactones of fluprostenol and related prostaglandin F2α analogs and their use in the treatment of glaucoma and intraocular hypertension' [patent_app_type] => utility [patent_app_number] => 12/036349 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 8962 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674921.pdf [firstpage_image] =>[orig_patent_app_number] => 12036349 [rel_patent_id] =>[rel_patent_doc_number] =>)